UNH
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated historical holders
total: 37
Brave Warrior Advisors UnitedHealth Group Incorporated transactions over time
- Total transactions:
- 19
- New positions:
- 2
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 12
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Glenn Greenberg has been an institutional investor in UnitedHealth Group Incorporated (UNH) since 2019 Q4. According to 2026 Q2 report, Glenn Greenberg holds 499 shares with a market value of roughly $207.40K representing 0.00% of their equity portfolio. The fund/company first acquired UNH in 2019 Q4, initially purchasing 159,089 shares. Glenn Greenberg later completely sold out the position and reinvested in UNH again in 2026 Q2. Since the initial investment, Brave Warrior Advisors has made 18 more transactions in this position.
Does Glenn Greenberg still hold UNH?
Yes, Glenn Greenberg continues to hold UnitedHealth Group Incorporated (UNH). According to their 2026 Q2 report, they maintain a position of 499 shares valued at approximately $207.40K, representing 0.00% of their equity portfolio.
When did Glenn Greenberg first invest in UNH?
Glenn Greenberg first invested in UnitedHealth Group Incorporated (UNH) in 2019 Q4 at the reported quarter-end price of $293.98 per share, acquiring 159,089 shares in their initial purchase.
What is Glenn Greenberg's average cost basis for UNH?
Based on historical transaction data, Glenn Greenberg's estimated cost basis for UnitedHealth Group Incorporated (UNH) is approximately $415.63 per share. This represents their average reported price* across all buy transactions.
Has Glenn Greenberg reinvested in UNH after selling?
Yes, Glenn Greenberg has shown renewed interest in UnitedHealth Group Incorporated (UNH). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $415.63
UNH transactions history by Brave Warrior Advisors
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
499
|
$415.63
|
$207,399
|
new
|
+0%
|
|
2025 Q3
|
0.00%
|
0
|
$311.97
|
|
-100% (-1,499)
|
-0.01%
|
|
2025 Q2
|
0.01%
|
1,499
|
$311.97
|
$467,643
|
+200.40% (+1,000)
|
+0.01%
|
|
2024 Q3
|
0.01%
|
499
|
$584.68
|
$291,755
|
-18.20% (-111)
|
-0%
|
|
2023 Q4
|
0.01%
|
610
|
$526.47
|
$321,147
|
-14.08% (-100)
|
-0%
|
|
2023 Q3
|
0.01%
|
710
|
$504.19
|
$357,975
|
-35.80% (-396)
|
-0.01%
|
|
2023 Q1
|
0.02%
|
1,106
|
$472.59
|
$522,685
|
-8.29% (-100)
|
-0%
|
|
2022 Q4
|
0.02%
|
1,206
|
$530.18
|
$639,397
|
-51.09% (-1,260)
|
-0.02%
|
|
2022 Q2
|
0.04%
|
2,466
|
$513.79
|
$1,267,000
|
-30.65% (-1,090)
|
-0.02%
|
|
2022 Q1
|
0.05%
|
3,556
|
$509.84
|
$1,813,000
|
-98.40% (-218,105)
|
-3.54%
|
|
2021 Q4
|
3.55%
|
$502.14
|
-1.97% (-4,460)
|
|||
|
2021 Q3
|
3.09%
|
$390.74
|
-6.57% (-15,898)
|
|||
|
2021 Q2
|
3.33%
|
$400.44
|
-1.79% (-4,411)
|
|||
|
2021 Q1
|
2.99%
|
$372.07
|
+51.08% (+83,316)
|
|||
|
2020 Q4
|
2.10%
|
$350.68
|
+2.01% (+3,213)
|
|||
|
2020 Q3
|
2.23%
|
$311.77
|
-3.38% (-5,590)
|
|||
|
2020 Q2
|
2.43%
|
$294.95
|
-37.10% (-97,609)
|
|||
|
2020 Q1
|
3.78%
|
$249.38
|
+65.38% (+104,011)
|
|||
|
2019 Q4
|
2.47%
|
$293.98
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.